162 related articles for article (PubMed ID: 21523380)
1. Possible prediction of underlying lymphoma by high sIL-2R/ferritin ratio in hemophagocytic syndrome.
Tabata C; Tabata R
Ann Hematol; 2012 Jan; 91(1):63-71. PubMed ID: 21523380
[TBL] [Abstract][Full Text] [Related]
2. A high sIL-2R/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome.
Tsuji T; Hirano T; Yamasaki H; Tsuji M; Tsuda H
Ann Hematol; 2014 May; 93(5):821-6. PubMed ID: 24705932
[TBL] [Abstract][Full Text] [Related]
3. High concentration of miR-133 is a useful marker for the diagnosis of lymphoma- associated hemophagocytic syndrome.
Li W; Zhong Y; Shuang Y; Huang H; Huang Y; Yu L; Huang X
Cancer Biomark; 2017 Aug; 20(2):159-164. PubMed ID: 28869447
[TBL] [Abstract][Full Text] [Related]
4. Plasma Levels of Presepsin (Soluble CD14-subtype) as a Novel Prognostic Marker for Hemophagocytic Syndrome in Hematological Malignancies.
Nanno S; Koh H; Katayama T; Hashiba M; Sato A; Makuuchi Y; Nagasaki J; Kuno M; Yoshimura T; Okamura H; Nishimoto M; Hirose A; Nakamae M; Nakane T; Hino M; Nakamae H
Intern Med; 2016; 55(16):2173-84. PubMed ID: 27522992
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review.
Lin M; Park S; Hayden A; Giustini D; Trinkaus M; Pudek M; Mattman A; Schneider M; Chen LYC
Ann Hematol; 2017 Aug; 96(8):1241-1251. PubMed ID: 28497365
[TBL] [Abstract][Full Text] [Related]
6. Identification of clinical features of lymphoma-associated hemophagocytic syndrome (LAHS): an analysis of 69 patients with hemophagocytic syndrome from a single-center in central region of China.
Li F; Li P; Zhang R; Yang G; Ji D; Huang X; Xu Q; Wei Y; Rao J; Huang R; Chen G
Med Oncol; 2014 Apr; 31(4):902. PubMed ID: 24610542
[TBL] [Abstract][Full Text] [Related]
7. Biomarker diversity in increased inflammation: Secondary hemophagocytic syndrome vs. systemic inflammatory response syndrome.
Bozgul SMK; Ak G; Soyer NA; Barutcuoglu B; Mercan E; Acar C; Yetişken M; Hekimgil M; Bozkurt D
Int J Lab Hematol; 2023 Apr; 45(2):213-220. PubMed ID: 36437601
[TBL] [Abstract][Full Text] [Related]
8. [Clinical characteristics of hemophagocytic syndrome: analysis of 46 cases].
Zhuo WB; Gao Y; Yang CY; Xu Y; Zhang YT; Zhu DM; Ping BH
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jun; 38(6):769-inside back cover. PubMed ID: 29997104
[TBL] [Abstract][Full Text] [Related]
9. Soluble interleukin-2 receptor (sIL-2r) level is a limited test for the diagnosis of adult secondary hemophagocytic lymphohistiocytosis.
Naymagon L; Tremblay D; Troy K; Mascarenhas J
Eur J Haematol; 2020 Sep; 105(3):255-261. PubMed ID: 32353917
[TBL] [Abstract][Full Text] [Related]
10. Serum sCD25/ferritin ratio combined with MCP-1 is a valid predictor for identifying LAHS with HLH as the first manifestation.
Zou H; He L; Hue Z; Liu M; Yao S; Zhu Y; Wang Z; Wang Y
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8521-8533. PubMed ID: 37093345
[TBL] [Abstract][Full Text] [Related]
11. Serum soluble interleukin-2 receptor (sIL-2R) is an accurate biomarker for dengue-associated hemophagocytic lymphohistiocytosis syndrome diagnosed by Hscore.
Mahabala C; Koushik VK; Manjrekar PA; Balanthimogru P
Infection; 2023 Apr; 51(2):433-438. PubMed ID: 35999341
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
Front Immunol; 2021; 12():750114. PubMed ID: 34691064
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum adenosine deaminase levels in secondary hemophagocytic lymphohistiocytosis.
Chen W; Zhang S; Zhang W; Yang X; Xu J; Qiu H; Zhang X; Li J
Int J Lab Hematol; 2015 Aug; 37(4):544-50. PubMed ID: 25764155
[TBL] [Abstract][Full Text] [Related]
14. IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome.
Maruoka H; Inoue D; Takiuchi Y; Nagano S; Arima H; Tabata S; Matsushita A; Ishikawa T; Oita T; Takahashi T
Ann Hematol; 2014 Mar; 93(3):393-401. PubMed ID: 23975214
[TBL] [Abstract][Full Text] [Related]
15. Lymphoma-associated hemophagocytic syndrome: a retrospective study from a single center.
Li N; Jiang M; Wu WC; Zhou HJ; Zou LQ
Hematology; 2022 Dec; 27(1):909-916. PubMed ID: 35993333
[TBL] [Abstract][Full Text] [Related]
16. Two cases of malignant lymphoma complicated by hemophagocytosis resembling orbital cellulitis.
Nakajima A; Abe T; Takagi T; Satoh N; Sakuragi S; Miura I; Wakui H; Oshima A; Horiuchi T; Ono S; Miura AB
Jpn J Ophthalmol; 1997; 41(3):186-91. PubMed ID: 9243316
[TBL] [Abstract][Full Text] [Related]
17. Measurement of the concentration of serum soluble interleukin-2 receptor alpha chain in dogs with lymphoma.
Mizutani N; Goto-Koshino Y; Kurata K; Fujiwara-Igarashi A; Sakaguchi M; Asada M; Ohno K; Tsujimoto H
Vet Immunol Immunopathol; 2020 Jul; 225():110054. PubMed ID: 32434088
[TBL] [Abstract][Full Text] [Related]
18. Hemophagocytic syndrome associated with large granular lymphoma in an adult dog.
Varvil MS; Messick JB; Dos Santos AP
Vet Clin Pathol; 2022 Mar; 51(1):115-118. PubMed ID: 35141916
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for survival of herpes simplex virus-associated hemophagocytic lymphohistiocytosis.
Sonoda M; Ishimura M; Eguchi K; Shiraishi A; Kanno S; Kaku N; Inoue H; Motomura Y; Ochiai M; Sakai Y; Nakayama M; Ohara O; Ohga S
Int J Hematol; 2020 Jan; 111(1):131-136. PubMed ID: 31549293
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and treatment of natural killer/T cell lymphoma associated with hemophagocytic syndrome: comparison with other T cell lymphoma associated with hemophagocytic syndrome.
Han L; Li L; Wu J; Li X; Zhang L; Wang X; Fu X; Ma W; Sun Z; Zhang X; Chang Y; Guo S; Zhang M
Leuk Lymphoma; 2014 Sep; 55(9):2048-55. PubMed ID: 24359240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
